Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023
20 March 2023 - 11:00PM
Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that it will release financial and business results for
the fourth quarter and full year 2022 after the close of trading on
Tuesday, March 28, 2023. Management will host a conference call
beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial
results and recent business developments.
A live webcast of the event will be available in
the “Investors” section of the Company’s website at
www.eksobionics.com, or by clicking here. Investors interested in
listening to the conference call may do so by dialing 877-407-3036
for domestic callers or 201-378-4919 for international callers.
A webcast replay will also be available on the
Company’s website for one month following the completion of the
call.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only known exoskeleton company
to offer technologies that range from helping those with paralysis
to stand up and walk, to enhancing human capabilities on job sites
across the globe. The Company is headquartered in the San Francisco
Bay Area and is listed on the Nasdaq Capital Market under the
symbol “EKSO.” For more information, visit: www.eksobionics.com or
follow @EksoBionics on Twitter.
Investor Contact: David Carey212-867-1768
investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024